BeOne Medicines (BEIGF) Tax Rate Growth (3y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Tax Rate Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.93 Bn | 625.17 Bn | 17.26 Bn |
| 2 | AbbVie | 443.06 Bn | 436.49 Bn | 12.70 Bn |
| 3 | Merck | 365.76 Bn | 358.62 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.47 Bn | 258.78 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.36 Bn | 44.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,787.00 |
| Mar 31, 2026 | 1,570.00 |
| Dec 31, 2025 | 5,877.00 |
| Sep 30, 2025 | 1,631.00 |
| Jun 30, 2025 | 671.00 |
| Mar 31, 2025 | 9,723.00 |
| Dec 31, 2024 | -7,729.00 |
| Sep 30, 2024 | -2,228.00 |
| Jun 30, 2024 | -1,372.00 |
| Mar 31, 2024 | 431.00 |
| Dec 31, 2023 | -90.00 |
| Sep 30, 2023 | 414.00 |
| Jun 30, 2023 | -416.00 |
| Mar 31, 2023 | -298.00 |
| Dec 31, 2022 | -135.00 |
| Sep 30, 2022 | -218.00 |
| Jun 30, 2022 | 108.00 |
| Mar 31, 2022 | -300.00 |
| Dec 31, 2021 | -376.00 |
| Sep 30, 2021 | -149.00 |